ArticleFrontiers in oncology2023

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination.

Chiara Masucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.